TO STUDY THE EFFECT OF VITAMIN-C AS AN ADDITIONAL THERAPY WITH ANTIDIABETIC DRUGS IN TYPE-2 DIABETES MELLITUS PATIENTS

Main Article Content

Dr. Stuti Singh
Dr. Palash Ratna
Dr. Luv Arya
Dr. Nashra Afaq
Dr. Nusrat Nabi
Dr. Firoza Bano
Dr.Saif Anees

Keywords

Vitamin C, Antidiabetic drug, Diabetes mellitus, Glimepiride, Voglibose

Abstract

INTRODUCTION: Diabetes mellitus is a metabolic condition characterised by hyperglycemia, which is commonly coupled with oxidative stress. Aside from hyperglycemia, oxidative stress plays a significant role in diabetes and its consequences, including diabetic neuropathy, nephropathy, and retinopathy. Reducing oxidative stress may improve the outcome of diabetes patients. The current study was designed to investigate the effect of oral hypoglycemic agents (OHA) and vitamin C on oxidative stress, lipid profile, and glycemic control.


AIM AND OBJECTIVE: To study the  effect of vitamin-c as an additional therapy with antidiabetic drugs in type-2 diabetes mellitus patients


MATERIAL AND METHODS: This was a prospective  study carried out in the Department of Pharmacology for a period of 12 months i.e, April 2023 to April 2024 at a tertiary care Centre. A total of 100 type-II diabetes mellitus patients were studied and divided into four groups, Group-A (Glimepiride), Group-B (Glimepiride + Vitamin-C), Group-C (Metformin + Voglibose) and Group-D (Metformin+ Voglibose+ Vitamin-C). Glycemic control, lipid profile and oxidative stress were compared before and after 3 months of treatment in all the 4 groups. The Data was analyzed By using SPSS Software.


RESULTS: In the present study after three months, all  the four groups had significant glycemic control (p<0.001), but only Groups B and D experienced significant reductions in oxidative stress (p<0.001). Groups B, C, and D showed significantly improved lipid control.


CONCLUSION: Vitamin-C supplementation in conjunction with OHA therapy improves glycemic control and lipid levels, and as an antioxidant, it decreases oxidative stress in diabetes mellitus patients.

Abstract 43 | pdf Downloads 6

References

1. El-Aal A.A., El-Ghffar E.A.A., Ghali A.A., Zughbur M.R., Sirdah M.M. The effect of vitamin C and/or E supplementations on type 2 diabetic adult males under metformin treatment: A single-blinded randomized controlled clinical trial. 2018; 12 (4) : pp. 483-489
2. Rahimi R, Nikfar S, Larijani B, Abdollahi M, et al. Biomed Pharmacother. 2005; 59(7):365-373.
3. Tiwari BK, Pandey KB, Abidi AB, Rizvi SI, et al. J Biomark, 2013; 378790.
4. Soumya D, Srilatha B. Late stage complications of diabetes and insulin resistance. J Diabetes Metab. 2011; 2: 167
5. Cho NH, Whiting D, Cavan D, et al. Diabetes Atla. 2015; 51-52.
6. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care. 2018; 41(1):13-27.
7. Bianchi C, Miccoli R, Daniele G, Penno G, Del Prato S, et al. Diabetes care. 2009; 2(2):342-348.
8. Bianchi C, Miccoli R, Daniele G, et al. Is there evidence that oral hypoglycemic agents reduce cardiovascular morbidity/mortality? Yes. Diabetes Care. 2009; 32(2): 342–348.
9. Ramachandaran A, Snehalatha C, Vijay V, et al. International Diabetes Moniter, 2003; 15(1):1-6.
10. Ramachandran A, Snehalatha C, Baskar, et al. Diabetologica, 2004; 47(1):860-863.
11. Wild S, Roglic G, Green A, Sicree R, King H, et al. Diabetes Care. 2004; 27(5):1047-1053.
12. BhattJK, ThomasS, NanjanM. Effect of oral supplementation of vitamin C on glycemic control and lipid profile in patients with type 2 diabetes mellitus. Int J Pharm Nanjing Sci. 2012;4:524–527.
13. GillaniSW, SulaimanSAS, AbdulMIM, BaigMR.Combined effect of metformin with ascorbic acid versus acetyl salicylic acid on diabetes-related cardiovascular complication; a 12-month single blind multicenter randomized control trial. Cardiovasc Diabetol. 2017;16:103.
14. ChenH, KarneRJ, Hall, et al. High-dose oral vitamin C partially replenishes vitamin C levels in patients with type 2 diabetes and low vitamin C levels but does not improve endothelial dysfunction or insulin resistance. Am J Physiol Heart Circ Physiol. 2006; 290:H137–H145.
15. DakhaleGN, ChaudhariHV, ShrivastavaM. Supplementation of vitamin C reduces blood glucose and improves glycosylated hemoglobin in type 2 diabetes mellitus: a randomized, double-blind study. Adv Pharmacol Sci. 2011; 195271.
16. Hadeel Delman Najim, Ibrahim Adham Majeed, Abbas Mahdi Rahmah, et al. International Journal of advances in Pharmacy, Biology and Chemistry, 2013; 2(2):323-327
17. Rekha Nayaka MR, et al. IJPR. 2015; 5(4):115-118
18. Dillu RD, Singh H, Bhardwaj BL, Singh KD, et al. 2016; 5(3):807-816.
19. Indirakumari N,.Vinutha S, Chandrakala Kambar et al. IOSR Journal of Dental and Medical Sciences. 2015; 14(1):13-22.
20. Faheem Mubeen MD, Deepak Bhosle, et al. Scholars Journal of Applied Medical Sciences. 2018; 6(9):3461- 3471
21. Kunsongkeit P, Okuma N, Rassameemasmaung S, Chaivanit P. Effect of vitamin C as an adjunct in nonsurgical periodontal therapy in uncontrolled type 2 diabetes mellitus patients. European journal of dentistry. 2019; 13(03):444-9.
22. Monitoring Editor: Alexander Muacevic and John R Adler. The Role of Vitamin C in Human Immunity and Its Treatment Potential Against COVID-19: A Review Article. Cureus. 2023; 15(1): e33740.
23. Kathleen M. Zelman, RD, LD, MPH. The Benefits of Vitamin C. 2024.